Bringing Cell and Gene Therapies to Patients: Innovating to Meet Unique Challenges

When: March 29, 2019, 5:30 pm - 8:30 pm
Where: bluebird bio, 60 Binney Street, Cambridge, MA

You’re invited to an evening at bluebird bio to hear about innovations in cell and gene therapy, and mingle with ISPE colleagues and friends.

You’re invited to an evening at bluebird bio to hear about innovations in cell and gene therapy, and mingle with ISPE colleagues and friends. Registration includes access to the networking reception prior to the educational program. Don’t delay – spots are limited! Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. The company develops and brings to market the most advanced products based on the transformative potential of gene therapy. This personalized approach to medicine presents challenges in gene and cell longevity, process flow, and manufacturing scale-up. We will discuss bluebird’s approach and innovations that address the resources, materials, and methods used to deliver these therapies to each patient.

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter